Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
No results were found for the filter!
Adintrevimab
Item number: TGM-T76900-10mg
Description: Adintrevimab (ADG 20), a human IgG1 monoclonal antibody, targets SARS-CoV (SARS-CoV) and demonstrates inhibition against SARS-CoV-2 variants as well as other SARS-like coronaviruses with pandemic potential [1]. Target: SARS-CoV
From 233.00€
*
Anbenitamab
Item number: TGM-T76905-10mg
Description: Anbenitamab (KN-026) is a bispecific antibody targeting extracellular domains II and IV of human HER2, blocking both ligand-dependent and independent signaling pathways. Its IgG1 Fc fragment activates FcRgammaIIIa, triggering strong antibody-dependent cell-mediated cytotoxicity (ADCC) and suppressing...
From 352.00€
*
Birtamimab
Item number: TGM-T76931-10mg
Description: Birtamimab (NEOD001) is a monoclonal antibody selectively targeting and depleting amyloid protein, used in research on light chain amyloidosis. Target: Beta Amyloid. References: Salzwedel K, et al. Maturation inhibitors: a new therapeutic class targets the virus structure. AIDS Rev. 2007...
| Keywords: | NEOD001 , NEOD 001 |
From 310.00€
*
Cantuzumab ravtansine
Item number: TGM-T76940-1mg
Description: Cantuzumab ravtansine (IMGN242, huC242-DM4), an antibody-drug conjugate (ADC), comprises the humanized monoclonal antibody huC242 covalently bonded through a disulfide linkage to the cytotoxic agent DM4 (DM4), demonstrating extensive antitumor effectiveness across various CanAg-positive human tumor...
Please request pricing for this article.
Vilobelimab
Item number: TGM-T76958-10mg
Description: Vilobelimab (CaCP-29) is a human-mouse chimeric IgG antibody targeting human complement component 5a, a C5a inhibitor that inhibits neutrophil activation, and can be used for the study of systemic inflammation caused by SARS-CoV-2 infection. Target: SARS-CoV, Complement System. References: Bauer M, et...
| Keywords: | CaCP29 , CaCP-29 , IFX1 , IFX-1 |
From 186.00€
*
Vibecotamab
Item number: TGM-T76959-10mg
Description: Vibecotamab (XmAb14045) is a potent bispecific antibody that targets CD123 and CD3, promoting T cell-mediated elimination of CD123-expressing cells. It exhibits antitumor properties and is used in studies on acute myeloid leukemia [1]. Target: Integrin
From 3,253.00€
*
Vepsitamab
Item number: TGM-T76961-1mg
Description: Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that targets CD3 on T cells and MUC17 on tumor cells, promoting targeted tumor cell destruction and stimulating T cell activation and proliferation [1]. Target: Integrin
510.00€
*
Tadocizumab
Item number: TGM-T76979-100mg
Description: Tadocizumab (C4G1) is a humanized monoclonal antibody targeting integrin alphaIIbbeta3 with antiplatelet and antithrombotic activity that blocks the platelet alphaIIbbeta3 integrin interac- with brinogen and bronectin, and can be used in the study of cardiovascular disease. Target: Integrin. References:...
| Keywords: | C4G 1 , YM-337 , C4G1 , YM337 |
From 281.00€
*
Teropavimab
Item number: TGM-T76982-10mg
Description: Teropavimab (3BNC117-LS), an antibody, is utilized in the research of HIV infection [1]. Target: HIV Protease
From 233.00€
*
Tecaginlimab
Item number: TGM-T76984-10mg
Description: Tecaginlimab (BNT-312), an Fc-inert bispecific antibody, is designed for the dual targeting and conditional activation of CD40 and 4-1BB, aiming to improve the priming and reactivation of tumor-specific immunity [1]. Target: TNF
From 392.00€
*
Tebotelimab
Item number: TGM-T76985-10mg
Description: Tebotelimab (MGD-013) is a bispecific antibody targeting PD-1 and LAG-3, classified as a human IgG4kappa dual-affinity re-targeting (DART) molecule. It has binding affinities with EC50 values of 1.65 nM for PD-1 and 0.41 nM for LAG-3 on NS0 cells. The compound inhibits PD-1/PD-L1, PD-1/PD-L2, and...
From 510.00€
*
Suvratoxumab
Item number: TGM-T76990-10mg
Description: Suvratoxumab (MEDI4893) is a high-affinity, long-acting humanized IgG1kappa anti-alpha-toxin monoclonal antibody. It effectively neutralizes alpha-toxin, a principal virulence factor of S. aureus, enhancing survival and diminishing lung injury in an immunocompromised mouse model of pneumonia....
From 233.00€
*